Neogen (NEOG) EPS (Basic) Growth (1y) (2011 - 2026)
Neogen (NEOG) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 13.85% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 97.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 97.48% |
| Feb 28, 2026 | -55.48% |
| Nov 30, 2025 | 96.52% |
| Aug 31, 2025 | 387.50% |
| May 31, 2025 | -11,907.36% |
| Feb 28, 2025 | -437.99% |
| Nov 30, 2024 | -12,960.89% |
| Aug 31, 2024 | -937.43% |
| May 31, 2024 | -174.03% |
| Feb 29, 2024 | -124.65% |
| Nov 30, 2023 | 91.68% |
| Aug 31, 2023 | -85.62% |
| May 31, 2023 | -74.41% |
| Feb 28, 2023 | -24.97% |
| Nov 30, 2022 | -292.45% |
| Aug 31, 2022 | -69.60% |
| May 31, 2022 | -1.96% |
| Feb 28, 2022 | -59.69% |
| Nov 30, 2021 | -32.71% |
| Aug 31, 2021 | 6.16% |